NDC 62225-300 – Yartemlea

Narsoplimab 370 mg/2mL · Injection · Intravenous

Human Prescription Drug

Product NDC62225-300

Product details

Brand name
Yartemlea
Generic name
narsoplimab
Labeler
Omeros Corporation
Dosage form
Injection
Route
Intravenous
Marketing category
BLA · BLA761152
Marketed since
January 20, 2026
Listing expires
December 31, 2027

Active ingredients

Uses, dosage, side effects and warnings for Yartemlea →

Package NDC codes (1)

Package NDCDescriptionSince
62225-300-001 VIAL in 1 CARTON (62225-300-00) / 2 mL in 1 VIALJan 20, 2026